Manufacturing‐dependent change in biological activity of the TLR4 agonist GSK1795091 and implications for lipid A analog development.

Autor: Steeghs, Neeltje1 (AUTHOR), Hansen, Aaron R.2 (AUTHOR), Hanna, Glenn J.3,4 (AUTHOR), Garralda, Elena5 (AUTHOR), Park, Haeseong6 (AUTHOR), Strauss, James7 (AUTHOR), Adam, Michael8 (AUTHOR), Campbell, Gossett8 (AUTHOR), Carver, Jennifer8 (AUTHOR), Easton, Rachael8 (AUTHOR), Mays, Katherine8 (AUTHOR), Skrdla, Peter8 (AUTHOR), Struemper, Herbert9 (AUTHOR), Washburn, Michael L.8 (AUTHOR), Matheny, Christopher8 (AUTHOR), Piha‐Paul, Sarina A.10 (AUTHOR) spihapau@mdanderson.org
Zdroj: CTS: Clinical & Translational Science. Nov2022, Vol. 15 Issue 11, p2625-2639. 15p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje